Cargando…
Eritoran insight for influenza treatment
A University of Maryland team has used a toll-like receptor 4 antagonist to treat influenza in mice. The results provide a repurposing opportunity for Eisai's TLR4 blocker Eritoran, originally developed for sepsis and could extend to treating respiratory infections beyond the flu.
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149081/ http://dx.doi.org/10.1038/scibx.2013.453 |
_version_ | 1783520737302151168 |
---|---|
author | Baas, Tracey |
author_facet | Baas, Tracey |
author_sort | Baas, Tracey |
collection | PubMed |
description | A University of Maryland team has used a toll-like receptor 4 antagonist to treat influenza in mice. The results provide a repurposing opportunity for Eisai's TLR4 blocker Eritoran, originally developed for sepsis and could extend to treating respiratory infections beyond the flu. |
format | Online Article Text |
id | pubmed-7149081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-71490812020-04-13 Eritoran insight for influenza treatment Baas, Tracey Science-Business eXchange Article A University of Maryland team has used a toll-like receptor 4 antagonist to treat influenza in mice. The results provide a repurposing opportunity for Eisai's TLR4 blocker Eritoran, originally developed for sepsis and could extend to treating respiratory infections beyond the flu. Nature Publishing Group US 2013 /pmc/articles/PMC7149081/ http://dx.doi.org/10.1038/scibx.2013.453 Text en © Nature Publishing Group 2013 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Baas, Tracey Eritoran insight for influenza treatment |
title | Eritoran insight for influenza treatment |
title_full | Eritoran insight for influenza treatment |
title_fullStr | Eritoran insight for influenza treatment |
title_full_unstemmed | Eritoran insight for influenza treatment |
title_short | Eritoran insight for influenza treatment |
title_sort | eritoran insight for influenza treatment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149081/ http://dx.doi.org/10.1038/scibx.2013.453 |
work_keys_str_mv | AT baastracey eritoraninsightforinfluenzatreatment |